Paper41367883
Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.
Huang J and 3 others. Onco Targets Ther, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer. Papers, record 41367883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41367883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36709038 | Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36709038 | PubMed |
| 2 | 40208442 | MLG2Net: Molecular Global Graph Network for Drug Response Prediction in Lung Cancer Cell Lines. | J Med Syst | 2025 | https://conductscience.org/library/papers/40208442 | PubMed |
| 3 | 27271951 | Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. | JAMA Neurol | 2016 | https://conductscience.org/library/papers/27271951 | PubMed |
| 4 | 31454760 | Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. | Neurol Neuroimmunol Neuroinflamm | 2019 | https://conductscience.org/library/papers/31454760 | PubMed |
| 5 | 33812689 | Neurological complications of immune checkpoint inhibitor cancer immunotherapy. | J Neurol Sci | 2021 | https://conductscience.org/library/papers/33812689 | PubMed |
| 6 | 31552550 | Epidemiology of paraneoplastic neurological syndromes: a population-based study. | J Neurol | 2020 | https://conductscience.org/library/papers/31552550 | PubMed |
| 7 | 28626408 | PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis. | Case Rep Oncol | 2017 | https://conductscience.org/library/papers/28626408 | PubMed |
| 8 | 34120259 | Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/34120259 | PubMed |
| 9 | 37523012 | Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer. | Funct Integr Genomics | 2023 | https://conductscience.org/library/papers/37523012 | PubMed |
| 10 | 29517954 | Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary. | J Oncol Pract | 2018 | https://conductscience.org/library/papers/29517954 | PubMed |
| 11 | 29441072 | Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature. | Front Immunol | 2018 | https://conductscience.org/library/papers/29441072 | PubMed |
| 12 | 35741658 | Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature. | Brain Sci | 2022 | https://conductscience.org/library/papers/35741658 | PubMed |
| 13 | 33454891 | Neurotoxicities associated with immune checkpoint inhibitor therapy. | J Neurooncol | 2021 | https://conductscience.org/library/papers/33454891 | PubMed |
| 14 | 36950965 | Immune checkpoint inhibitor-induced autoimmune encephalitis in metastatic squamous cell lung cancer. | Immunotherapy | 2023 | https://conductscience.org/library/papers/36950965 | PubMed |
| 15 | 27718847 | Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718847 | PubMed |
| 16 | 33653902 | Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review. | Neurology | 2021 | https://conductscience.org/library/papers/33653902 | PubMed |
| 17 | 32086972 | Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. | Ann Neurol | 2020 | https://conductscience.org/library/papers/32086972 | PubMed |
| 18 | 33268558 | Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis. | Neurology | 2021 | https://conductscience.org/library/papers/33268558 | PubMed |
| 19 | 30073101 | Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma. | Case Rep Neurol Med | 2018 | https://conductscience.org/library/papers/30073101 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41367883
GET https://conductscience.org/api/papers/v1/41367883/authors